WSAZ Now Desk | Doctor talks about being involved in clinical trials of new Alzheimer’s treatment

Dr. Douglas Scharre, a neurologist at Ohio State Wexner Medical Center, joins the WSAZ Now Desk to talk about a new Alzheimer's treatment approved by the FDA.
Updated: Jun. 10, 2021 at 4:06 PM EDT

COLUMBUS, Ohio (WSAZ) - Dr. Douglas Scharre, a neurologist and director of the division of Cognitive Neurology at Ohio State Wexner Medical Center, joins the WSAZ Now Desk to talk about a new Alzheimer’s treatment approved by the FDA.

Copyright 2021 WSAZ. All rights reserved.